Lantheus Holdings Inc Cash Flow Conversion Efficiency
Lantheus Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, Lantheus Holdings Inc (LNTH) has a cash flow conversion efficiency ratio of 0.083x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($90.18 Million) by net assets ($1.09 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Lantheus Holdings Inc (2012–2025)
Cash flow conversion efficiency of Lantheus Holdings Inc from 2012 to 2025. This chart illustrates how Lantheus Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View LNTH stock price and chart for real-time trading data and today's change.
Lantheus Holdings Inc Cash Flow Conversion Ratio Explained
Lantheus Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Lantheus Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lantheus Holdings Inc ranked by their cash flow conversion efficiency. Also see market value of Lantheus Holdings Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arkema SA
PA:AKE
|
0.001x |
|
Ollie's Bargain Outlet Hldg
NASDAQ:OLLI
|
0.024x |
|
Beijing Roborock Technology Co Ltd
SHG:688169
|
-0.014x |
|
ChampionX Corporation
NASDAQ:CHX
|
0.035x |
|
Sonoco Products Company
NYSE:SON
|
-0.103x |
|
Radian Group Inc
NYSE:RDN
|
0.018x |
|
Macy’s Inc
NYSE:M
|
0.243x |
|
White Mountains Insurance Group Ltd
NYSE:WTM
|
0.028x |
Annual Cash Flow Conversion Efficiency for Lantheus Holdings Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of Lantheus Holdings Inc from 2012 to 2025. Review Lantheus Holdings Inc free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.09 Billion | $390.14 Million | 0.358x | -28.50% |
| 2024-12-31 | $1.09 Billion | $544.75 Million | 0.501x | +33.82% |
| 2023-12-31 | $815.89 Million | $305.26 Million | 0.374x | -40.63% |
| 2022-12-31 | $447.15 Million | $281.78 Million | 0.630x | +442.84% |
| 2021-12-31 | $464.44 Million | $53.92 Million | 0.116x | +264.07% |
| 2020-12-31 | $514.21 Million | $16.40 Million | 0.032x | -95.45% |
| 2019-12-31 | $114.60 Million | $80.38 Million | 0.701x | -18.61% |
| 2018-12-31 | $71.00 Million | $61.19 Million | 0.862x | -63.35% |
| 2017-12-31 | $23.29 Million | $54.78 Million | 2.352x | +604.63% |
| 2016-12-31 | $-106.52 Million | $49.64 Million | -0.466x | -296.81% |
| 2015-12-31 | $-185.29 Million | $21.76 Million | -0.117x | -142.47% |
| 2014-12-31 | $-239.27 Million | $11.59 Million | -0.048x | -173.26% |
| 2013-12-31 | $-235.52 Million | $-15.57 Million | 0.066x | +2976.73% |
| 2012-12-31 | $-173.10 Million | $-372.00K | 0.002x | -- |
About Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceut… Read more